Advertisement
Screener

TETRALOGIC PHARMACEUTICALS CORP Net Income

TETRALOGIC PHARMACEUTICALS CORP Net Income

TETRALOGIC PHARMACEUTICALS CORP reported Net Income of -$8.63 million for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-03.

Discontinued › Income Statement › Net Income

us-gaap:NetIncomeLoss · last filed 2016-11-03

  • TETRALOGIC PHARMACEUTICALS CORP net income (loss) attributable to parent for the quarter ending 2016-09-30 was -$8.63M.
  • TETRALOGIC PHARMACEUTICALS CORP net income (loss) attributable to parent for the quarter ending 2016-06-30 was -$6.75M.
  • TETRALOGIC PHARMACEUTICALS CORP net income (loss) attributable to parent for the quarter ending 2016-03-31 was -$11.07M.
  • TETRALOGIC PHARMACEUTICALS CORP net income (loss) attributable to parent for the quarter ending 2015-12-31 was -$14.27M.
  • TETRALOGIC PHARMACEUTICALS CORP net income (loss) attributable to parent for fiscal 2015 was -$49.72M.
  • TETRALOGIC PHARMACEUTICALS CORP net income (loss) attributable to parent for fiscal 2014 was -$35.96M.
  • TETRALOGIC PHARMACEUTICALS CORP net income (loss) attributable to parent for fiscal 2013 was -$19.95M.
Period endNet Income (Loss) Attributable to Parent 3 monthNet Income (Loss) Attributable to Parent 6 monthNet Income (Loss) Attributable to Parent 9 monthNet Income (Loss) Attributable to Parent 12 monthNet Income (Loss) Attributable to Parent 126 month
2016-09-30-$8.63M
10-Q · filed 2016-11-03
-$15.38M
derived: sum of 2 quarters · filed 2016-11-03
-$26.45M
10-Q · filed 2016-11-03
-$40.72M
derived: sum of 4 quarters · filed 2016-11-03
2016-06-30-$6.75M
10-Q · filed 2016-08-11
-$17.81M
10-Q · filed 2016-08-11
-$32.08M
derived: sum of 3 quarters · filed 2016-08-11
-$42.98M
derived: sum of 4 quarters · filed 2016-11-03
2016-03-31-$11.07M
10-Q · filed 2016-05-04
-$25.34M
derived: sum of 2 quarters · filed 2016-05-04
-$36.23M
derived: sum of 3 quarters · filed 2016-11-03
-$48.11M
derived: sum of 4 quarters · filed 2016-11-03
2015-12-31-$14.27M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-16
-$25.17M
derived: sum of 2 quarters · filed 2016-11-03
-$37.04M
derived: sum of 3 quarters · filed 2016-11-03
-$49.72M
10-K · filed 2016-03-16
2015-09-30-$10.90M
10-Q · filed 2016-11-03
-$22.77M
derived: sum of 2 quarters · filed 2016-11-03
-$35.45M
10-Q · filed 2016-11-03
-$47.39M
derived: sum of 4 quarters · filed 2016-11-03
2015-06-30-$11.87M
10-Q · filed 2016-08-11
-$24.56M
10-Q · filed 2016-08-11
-$36.50M
derived: sum of 3 quarters · filed 2016-08-11
-$45.83M
derived: sum of 4 quarters · filed 2016-08-11
2015-03-31-$12.68M
10-Q · filed 2016-05-04
-$24.62M
derived: sum of 2 quarters · filed 2016-05-04
-$33.95M
derived: sum of 3 quarters · filed 2016-05-04
-$43.31M
derived: sum of 4 quarters · filed 2016-05-04
2014-12-31-$11.94M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-16
-$21.27M
derived: sum of 2 quarters · filed 2016-03-16
-$30.62M
derived: sum of 3 quarters · filed 2016-03-16
-$35.96M
10-K · filed 2016-03-16
2014-09-30-$9.33M
10-Q · filed 2015-11-04
-$18.68M
derived: sum of 2 quarters · filed 2015-11-04
-$24.02M
10-Q · filed 2015-11-04
-$30.67M
derived: sum of 4 quarters · filed 2015-11-04
2014-06-30-$9.35M
10-Q · filed 2015-08-05
-$14.69M
10-Q · filed 2015-08-05
-$21.34M
derived: sum of 3 quarters · filed 2015-08-05
-$27.32M
derived: sum of 4 quarters · filed 2015-08-05
2014-03-31-$5.33M
10-Q · filed 2015-05-14
-$11.99M
derived: sum of 2 quarters · filed 2015-05-14
-$17.96M
derived: sum of 3 quarters · filed 2015-05-14
-$21.86M
derived: sum of 4 quarters · filed 2015-05-14
-$95.21M
10-Q · filed 2014-05-08
2013-12-31-$6.65M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26
-$12.63M
derived: sum of 2 quarters · filed 2015-02-26
-$16.52M
derived: sum of 3 quarters · filed 2015-02-26
-$19.95M
10-K · filed 2015-02-26
2013-09-30-$5.98M
10-Q · filed 2014-11-05
-$9.87M
derived: sum of 2 quarters · filed 2014-11-05
-$13.30M
10-Q · filed 2014-11-05
2013-06-30-$3.89M
10-Q · filed 2014-08-05
-$7.32M
10-Q · filed 2014-08-05
2013-03-31-$3.43M
10-Q · filed 2014-05-08